Cargando…
Myxoinflammatory Fibroblastic Sarcoma of the Hand
Myxoinflammatory fibroblastic sarcoma is an ultra-rare tumor type with a prevalence of fewer than two per 100,000 people. The tumor poses a challenge because it can be misdiagnosed as a benign lesion in clinical and radiological investigations, causing serious morbidity in patients. We present the c...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106128/ https://www.ncbi.nlm.nih.gov/pubmed/37073254 http://dx.doi.org/10.1097/GOX.0000000000004934 |
_version_ | 1785026358907240448 |
---|---|
author | Alhumaidan, Mohammed I. Bin Makhashen, Maraei Bassas, Abdulelah F. Mater, Mohammed E. Alsufayan, Faris A. Alfaqeeh, Faisal A. |
author_facet | Alhumaidan, Mohammed I. Bin Makhashen, Maraei Bassas, Abdulelah F. Mater, Mohammed E. Alsufayan, Faris A. Alfaqeeh, Faisal A. |
author_sort | Alhumaidan, Mohammed I. |
collection | PubMed |
description | Myxoinflammatory fibroblastic sarcoma is an ultra-rare tumor type with a prevalence of fewer than two per 100,000 people. The tumor poses a challenge because it can be misdiagnosed as a benign lesion in clinical and radiological investigations, causing serious morbidity in patients. We present the case of a 33-year-old patient who presented with painless hand swelling that was misdiagnosed as lymphaticovenous malformation based on magnetic resonance imaging. The patient underwent surgical excision, and myxoinflammatory fibroblastic sarcoma was diagnosed postoperatively. All surgical interventions failed to achieve negative margin. A decision to start radiotherapy was made, and tissue convergence was done temporally using acellular dermal matrix and split-thickness skin graft. On patient follow-up, the graft had taken well, and the patient was undergoing radiotherapy sessions with a plan for permanent hand reconstruction after negative margins are achieved. Based on this case report, we identified that magnetic resonance imaging is not yet a reliable method to diagnose myxoinflammatory fibroblastic sarcoma. Therefore, implementing a multidisciplinary team approach, a preoperative core needle biopsy, planned surgical intervention, and early involvement of radiotherapy is recommended to minimize morbidity. We strongly urge establishing a sarcoma specialized treatment center in the region to limit patient morbidity. |
format | Online Article Text |
id | pubmed-10106128 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101061282023-04-17 Myxoinflammatory Fibroblastic Sarcoma of the Hand Alhumaidan, Mohammed I. Bin Makhashen, Maraei Bassas, Abdulelah F. Mater, Mohammed E. Alsufayan, Faris A. Alfaqeeh, Faisal A. Plast Reconstr Surg Glob Open Hand Myxoinflammatory fibroblastic sarcoma is an ultra-rare tumor type with a prevalence of fewer than two per 100,000 people. The tumor poses a challenge because it can be misdiagnosed as a benign lesion in clinical and radiological investigations, causing serious morbidity in patients. We present the case of a 33-year-old patient who presented with painless hand swelling that was misdiagnosed as lymphaticovenous malformation based on magnetic resonance imaging. The patient underwent surgical excision, and myxoinflammatory fibroblastic sarcoma was diagnosed postoperatively. All surgical interventions failed to achieve negative margin. A decision to start radiotherapy was made, and tissue convergence was done temporally using acellular dermal matrix and split-thickness skin graft. On patient follow-up, the graft had taken well, and the patient was undergoing radiotherapy sessions with a plan for permanent hand reconstruction after negative margins are achieved. Based on this case report, we identified that magnetic resonance imaging is not yet a reliable method to diagnose myxoinflammatory fibroblastic sarcoma. Therefore, implementing a multidisciplinary team approach, a preoperative core needle biopsy, planned surgical intervention, and early involvement of radiotherapy is recommended to minimize morbidity. We strongly urge establishing a sarcoma specialized treatment center in the region to limit patient morbidity. Lippincott Williams & Wilkins 2023-04-14 /pmc/articles/PMC10106128/ /pubmed/37073254 http://dx.doi.org/10.1097/GOX.0000000000004934 Text en Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Hand Alhumaidan, Mohammed I. Bin Makhashen, Maraei Bassas, Abdulelah F. Mater, Mohammed E. Alsufayan, Faris A. Alfaqeeh, Faisal A. Myxoinflammatory Fibroblastic Sarcoma of the Hand |
title | Myxoinflammatory Fibroblastic Sarcoma of the Hand |
title_full | Myxoinflammatory Fibroblastic Sarcoma of the Hand |
title_fullStr | Myxoinflammatory Fibroblastic Sarcoma of the Hand |
title_full_unstemmed | Myxoinflammatory Fibroblastic Sarcoma of the Hand |
title_short | Myxoinflammatory Fibroblastic Sarcoma of the Hand |
title_sort | myxoinflammatory fibroblastic sarcoma of the hand |
topic | Hand |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106128/ https://www.ncbi.nlm.nih.gov/pubmed/37073254 http://dx.doi.org/10.1097/GOX.0000000000004934 |
work_keys_str_mv | AT alhumaidanmohammedi myxoinflammatoryfibroblasticsarcomaofthehand AT binmakhashenmaraei myxoinflammatoryfibroblasticsarcomaofthehand AT bassasabdulelahf myxoinflammatoryfibroblasticsarcomaofthehand AT matermohammede myxoinflammatoryfibroblasticsarcomaofthehand AT alsufayanfarisa myxoinflammatoryfibroblasticsarcomaofthehand AT alfaqeehfaisala myxoinflammatoryfibroblasticsarcomaofthehand |